Chardan Details?
Just curious to learn more about Chardan. Don't know much about them, but they seem like a sizeable bank.
Do they take SA's, how is comp, exit opps, rep?
Thank you!
Trending Content - Investment Banking Forum
| +313 | I Snuck Into UBS Office And Took A Shit On The Floor | 28 | 1d |
| +249 | Houston 2026 Oil & Gas Investment Banking Rankings | 67 | 1h |
| +244 | Why leave restructuring for M&A? | 31 | 1h |
| +232 | Best Power/Renewables/Energy Teams? | 39 | 11h |
| +209 | Predicted 1Q 2027 Story - UBS IB blames Outlook Outage for Down Quarter | 37 | 8h |
| +188 | Centerview HC group falling off? | 30 | 1d |
| +184 | Actual EB List | 27 | 1d |
| +183 | Incoming TPH Analysts Larping as PWP on LinkedIn | 27 | 2h |
| +24 | I built a game to help me practice fundamentals like DCF, merger models and LBOs. Roast it? | 6 | 3h |
| +22 | What’s the current state of IBD at BofA? | 26 | 1d |
Career Resources
Bump
bump
Chardan is a SPAC powerhouse that has had an absolutely killer past several years.
With a lot of SPACs not successfully de-SPACing anymore and returning capital to investors, the sponsors got burned because they have paid a bunch of fees to a banker like Chardan, EarlyBird, or a BB bank’s ECM team. This is what kills the deal flow.
SPACs are the red-headed stepchild of Wall Street right now, but if you love the product, there will always be more SPACs.
Feel free to ask any follow-ons about the product.
Do you have any info on their equity research team? Seems like this is still connected to their SPAC practice but not exactly sure how.
Is it just SPAC sponsors paying for coverage?
They don’t cover a ton of stocks. Most of the stocks are biotech, which makes sense given that it was a popular de-SPAC target market. Most of the biotech stocks were actually never SPACs; I think it’s just a core competency they had and felt they understood.
Then there’s the other tech coverage, and that list reads like a who’s who of SPACs. BMTX, PLBY, KITT, PRST, PET, etc. Giving coverage of the stock after the fact supports the IPO activity of the firm and is good karma.
I think they have a small, but non-SPAC biotech arm which evolved from their de-SPAC activities, and they cover some of their own cooking on the SPAC side as goodwill.
Very helpful, do you have any color on culture, WLB, bonus figures, etc.
Quis placeat ea odit rerum enim. Ut earum quia omnis quod cumque nihil. Sit et dolorem eligendi qui blanditiis.
Molestiae ea occaecati qui veniam eos laboriosam nihil. Nisi voluptas dolor numquam ipsam omnis omnis facilis. Ad omnis incidunt vitae veritatis et harum. Aperiam dolores perspiciatis sed atque. Aut corrupti tempora voluptatibus et.
Quia rerum nihil aliquid. Id accusantium dolorum tempore consequuntur aspernatur magni. Nulla est ad esse velit. Incidunt ipsum non qui.
Minima enim itaque perspiciatis nihil hic. Tempora accusamus inventore unde quod ratione eaque consequuntur.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...